COMORBIDADE PSIQUIATRICA NO DIABETES MELLITUS DO TIPO 2: DO DIAGNOSTICO AO TRATAMENTO





COMORBIDADE PSIQUIATRICA NO DIABETES MELLITUS DO TIPO 2: DO DIAGNOSTICO AO TRATAMENTO

(especial para SIIC © Derechos reservados)
A presença de comorbidade psiquiátrica parece aumentada no diabetes mellitus. Em função do possível impacto desses transtornos no curso do diabetes, seu tratamento é importante para um controle metabólico adequado.
papelbaum9.jpg Autor:
Marcelo Papelbaum
Columnista Experto de SIIC
Artículos publicados por Marcelo Papelbaum
Recepción del artículo
27 de Enero, 2007
Aprobación
9 de Mayo, 2007
Primera edición
13 de Agosto, 2007
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
O diabetes mellitus (DM) é uma doença crônica caracterizada por um conjunto de alterações metabólicas que compartilham entre si uma hiperglicemia persistente. Apesar de todos os esforços no controle da doença, um grupo de pacientes com diabetes permanece com níveis glicêmicos elevados e evolui com complicações clínicas associadas, mesmo seguindo orientações terapêuticas específicas. A presença de transtornos psiquiátricos no DM poderia ser um dos fatores que dificultaria o controle metabólico e facilitaria a evolução da doença. O objetivo desse artigo foi o de investigar a associação entre comorbidade psiquiátrica, principalmente a depressão e os transtornos alimentares (TA), e o diabetes mellitus do tipo 2 (DM2). A ocorrência de depressão e dos TA parece aumentada em pacientes com diabetes. Além disso, a presença de uma síndrome depressiva e de sintomas alimentares parece influenciar negativamente o controle metabólico da doença. Parece importante investigar a presença de um transtorno psiquiátrico em pacientes com diabetes, sobretudo naqueles que não conseguem um controle metabólico satisfatório. O tratamento adequado de um TA no diabetes poderia estar associado com uma redução das complicações clínicas relacionadas ao diabetes.

Palabras clave
diabetes mellitus, depressão, transtornos alimentares, compulsão alimentar, controle metabólico


Artículo completo

(castellano)
Extensión:  +/-5.07 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Diabetes mellitus (DM) is a chronic disease characterized by a group of metabolic alterations that have in common a persistent hyperglycemia. Despite all efforts to control the disease, a group of diabetic patients remains with increased glycemic levels, developing associated clinical complications later on, even after following specific therapeutical recommendations. The presence of psychiatric disorders in DM could be one of the factors that disturb the metabolic control, facilitating the progression of the disease. The goal of this article was to investigate the association between psychiatric comorbidity, particularly depression and eating disorders (ED), and type 2 diabetes mellitus (T2DM). The occurrence of depression and ED seems to be increased in patients with diabetes. Furthermore, the presence of a depression syndrome and eating disorder symptoms seems to negatively influence metabolic control. of the disease. It seems important to investigate the presence of a psychiatric disorder in patients with diabetes, especially in those who cannot achieve a satisfactory metabolic control. The adequate treatment of an eating disorder in diabetes could be associated with a reduction in the number of clinical complications related to this disease.

Key words
diabetes mellitus, depression, eating disorders, binge eating, metabolic control


Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Diabetología
Relacionadas: Atención Primaria, Farmacología, Geriatría, Medicina Familiar, Medicina Farmacéutica, Medicina Interna, Salud Mental



Comprar este artículo
Extensión: 5.07 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Marcelo Papelbaum, Instituto Estadual de Diabetes e Endocrinologia do Rio de Janeiro (Iede-Rj) , 22421-000, Rua barão de jaguaripe 63 ; apt 401 ipanema, Róo de Janeiro, Brasil
Bibliografía del artículo
1. Alberti KGMM, Zimet PZ. The WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabetic Medicine 15:539-53, 1998.
2. Centers for Disease Control and Prevention. Diabetes in the United States: a strategy for prevention; Progress Report. Atlanta, GA: Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 3-12, 1993.
3. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 years. The brazilian cooperative group on the study of diabetes prevalence. Diabetes Care 15:1509-16,1992.
4. Takki M, Komaki G, Ucjigata Y, Maeda M, Omori Y, Kubo C. Differences between bulimia nervosa and binge-eating disorder in females with type 1 diabetes: the important role of insulin omission. Journal of Psychosomatic Research 47(3):221-31, 1999.
5. Vijan S, Hayward RA, Langa KM. The impact of diabetes on workforce participation: results from a national household sample. Health Services Research 39( 6Pt1):1653-69, 2004.
6. Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. Jornal of Clinical Psychology 57(4):457-78, 2001.
7. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The Prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6):1069-78, 2001.
8. Moreira RO, Papelbaum M, Appolinário JC e cols. Diabetes mellitus e depressão: uma revisão sistemática. Arquivos Brasileiros de Endocrinologia e Metabologia 47(1):19-29, 2003.
9. Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. Psychosomatic Research 53(6):1053-60, 2002.
10. Papelbaum M, Appolinário JC, Moreira RO, Ellinger VCM, Kupfer R, Coutinho WF. Prevalência de transtornos alimentares e comorbidade psiquiátrica em uma amostra clínica de pacientes com diabetes mellitus do tipo 2. Revista Brasileira de Psiquiatria 27(2):135-8, 2005.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington DC: American Psychiatric Press 1980.
12. Papelbaum M, Moreira RO, Coutinho WF e cols. Diabetes mellitus e transtornos alimentares: uma revisão sistemática. Jornal Brasileiro de Psiquiatria 53(3):163-73, 2004.
13. Yanovski SZ, Gormally JF, Lesser MS, Gwirtsman HE, Yanovski JA. Binge eating disorder affects outcome of comprehensive very-low-calorie diet treatment. Obesity Research 2:205-212, 1994.
14. Blundell JE. Serotonin manipulations and the structure of feeding behavior. Appetite 7(Suppl):39-56, 1986.
15. De Zwaan M, Mitchell JE, Seim HC e cols. Eating related and general psychopathology in obese females with binge eating disorder. International Journal of Eating Disorders 15(1):43-52, 1994.
16. Kalsekar ID, Madhavan SS, Amonkar MM e cols. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Clinical Therapeutics 28(2):306-18, 2006.
17. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes type 1 and 2: epidemiology, biology and treatment. Biological Psychiatry 54(3):317-29, 2003.
18. Virk S, Schwartz TL, Jindal S, Nihalani N, Jones N. Psichiatric medication induced obesity: an aetiologic review. Obesity Reviews 5(3):167-70, 2004.
19. Moreira RO, Castro AP, Papelbaum M, Appolinário JC, Ellinger VC, Coutinho WF, Zagury L. Translation into Portuguese and assessment of the reliability of a scale for the diagnosis of diabetic distal polyneuropathy. Arquivos Brasileiros de Endocrinologia e Metabologia 49(6):944-50, 2005.
20. Moreira RO, Papelbaum M, Fontenelle LF e cols. Comorbidity of psychiatric disorders and symmetric distal polyneuropathy among type II diabetic outpatients. Brazilian Journal of Medical and Biological Research [online] 2006.
21. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Annals of Internal Medicine 129(8):613-21, 1998.
22. Lustman PJ, Clouse RE, Nix BD e cols. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Archives of General Psychiatry 63(5)521-9, 2006.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618